We are live on ! Find out more
MCP

Maso Capital Partners Portfolio holdings

AUM $60.9M
1-Year Est. Return 0.32%
This Fund
S&P 500
This Quarter Est. Return
+2.64%
1 Year Est. Return
-0.32%
3 Year Est. Return
+8.67%
5 Year Est. Return
-6.95%
10 Year Est. Return
–
AUM
$191M
AUM Growth
+$45.2M
Cap. Flow
+$38.1M
Cap. Flow %
20.01%
Top 10 Hldgs %
90.31%
Holding
21
New
4
Increased
8
Reduced
4
Closed
2

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$35.1M
2
BPL
Buckeye Partners, L.P.
BPL
+$24.7M
3
RHT
Red Hat Inc
RHT
+$13.3M
4
HUYA
Huya Inc
HUYA
+$1.58M
5
HCM icon
HUTCHMED
HCM
+$1.28M

Top Sells

Rank Stock Value
1
BMS
Bemis
BMS
+$26.2M
2
SE icon
Sea Limited
SE
+$1.68M
3
CBPO
China Biologic Products Holdings, Inc.
CBPO
+$1.27M
4
YUMC icon
Yum China
YUMC
+$782K
5
TAK icon
Takeda Pharmaceutical
TAK
+$29.1K

Sector Composition

Rank Sector Weight
1 Healthcare 30.26%
2 Communication Services 22.06%
3 Energy 14.06%
4 Financials 5.74%
5 Consumer Discretionary 5.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$49.6M 26.04%
537,000
+369,500
+221% +$35.1M
RHT
2
DELISTED
Red Hat Inc
RHT
$35.9M 18.82%
191,100
+72,100
+61% +$13.3M
BPL
3
DELISTED
Buckeye Partners, L.P.
BPL
$26.8M 14.06%
+653,255
New +$24.7M
CBPO
4
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$14.4M 7.55%
151,034
-13,466
-8% -$1.27M
GNW icon
5
Genworth Financial
GNW
$3.86B
$10.9M 5.74%
2,947,500
+270,700
+10% +$959K
BG icon
6
Bunge Global
BG
$20.9B
$8.49M 4.45%
152,331
+18,060
+13% +$963K
BABA icon
7
CALL
Alibaba
BABA
$276B
$8.47M 4.44%
500
-76,500
-99% -$13.2M
YUMC icon
8
Yum China
YUMC
$15.7B
$7.39M 3.88%
160,000
-18,000
-10% -$782K
CYOU
9
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$5.37M 2.82%
558,800
+56,500
+11% +$871K
ACHC icon
10
Acadia Healthcare
ACHC
$2.55B
$4.8M 2.52%
137,400
+29,200
+27% +$944K
SOHU
11
Sohu.com
SOHU
$352M
$4.48M 2.35%
319,800
+25,300
+9% +$400K
MLCO icon
12
Melco Resorts & Entertainment
MLCO
$2.21B
$3.14M 1.65%
144,500
+24,500
+20% +$556K
TAK icon
13
Takeda Pharmaceutical
TAK
$56.7B
$2.26M 1.19%
127,771
-1,600
-1% -$29.1K
HUYA
14
Huya Inc
HUYA
$558M
$1.7M 0.89%
+68,800
New +$1.58M
BYND icon
15
Beyond Meat
BYND
$274M
$1.06M 0.56%
+6,600
New +$736K
HCM icon
16
HUTCHMED
HCM
$1.96B
$990K 0.52%
+45,000
New +$1.28M
CENN icon
17
Cenntro
CENN
$8.58M
$288K 0.15%
2
– –
SE icon
18
Sea Limited
SE
$66.4B
– –
-71,400
Closed -$1.68M
BMS
19
DELISTED
Bemis
BMS
– –
-472,803
Closed -$26.2M

Similar funds

GVIC
Global Value Investment Corporation Milwaukee, Wisconsin $61.5M AUM 18.19% 1-Year Est. Return
MA
MAS Advisors Miami, Florida $63.2M AUM 9.63% 1-Year Est. Return
ITVII
IDG Technology Venture Investment IV Hong Kong $58.3M AUM 89.42% 1-Year Est. Return
MIG
Mithril II GP Austin, Texas $64.5M AUM 360.75% 1-Year Est. Return
LAM
Lingohr Asset Management Duesseldorf, Germany $57.3M AUM 35.27% 1-Year Est. Return
NCFG
New Century Financial Group Princeton, New Jersey $56.3M AUM 16.99% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return

Maso Capital Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Maso Capital Partners held 21 positions worth $191M, up 31% from $145M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Maso Capital Partners deployed $38.1M of net new capital in Q2 2019, opening 4 new positions and adding to 8 existing holdings. Its largest new stake was Buckeye Partners, L.P.: 653,255 shares worth $26.8M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 15% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was China Biologic Products Holdings, Inc., an estimated $1.27M trimmed.

  • Maso Capital Partners's largest Q2 2019 buy was Buckeye Partners, L.P.: 653,255 shares worth $26.8M.
  • Maso Capital Partners added most to Celgene Corp in Q2 2019, an estimated $35.1M increase.
  • Maso Capital Partners's biggest Q2 2019 reduction was China Biologic Products Holdings, Inc., cutting an estimated $1.27M.
  • Maso Capital Partners fully exited Bemis in Q2 2019, selling an estimated $26.2M.
  • Maso Capital Partners's ten largest holdings make up 90% of its $191M portfolio in Q2 2019.
  • Maso Capital Partners opened 4 new positions and closed 2 in Q2 2019.
  • Maso Capital Partners's portfolio value rose 31% quarter-over-quarter to $191M.

Based on Maso Capital Partners's 13F filing for Q2 2019, filed 13 Aug 2019.